The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study

Conditions

• Hepatitis C, Chronic

Interventions

• DRUG: Epclusa (SOF/VEL)
• DRUG: Standard of care
• DEVICE: Fibroscan® 430 Mini Plus

Sponsor

University of California, San Francisco

Collaborators

• [object Object]